Alpha Tau Medical (DRTS) Total Non-Current Liabilities (2020 - 2026)

Alpha Tau Medical (DRTS) posted Total Non-Current Liabilities of $29.0 million for Q1 2026, up 60.55% sequentially from $18.0 million in Q4 2025, and up 95.28% YoY from $14.8 million in Q1 2025.

Alpha Tau Medical (DRTS) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

Alpha Tau Medical has reported Total Non-Current Liabilities for 7 years, with the latest figure at $29.0 million in Q1 2026.

  • Quarterly Total Non-Current Liabilities rose 95.28% year-over-year to $29.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.0 million (up 95.28% YoY) and the FY2025 annual result came in at $18.0 million, up 21.42% from the prior year.
  • Total Non-Current Liabilities rose to $29.0 million in Q1 2026 per DRTS's latest filing, from $18.0 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $29.0 million in Q1 2026 and troughed at $8.1 million in Q1 2022.
  • A 5-year average of $15.2 million and a median of $15.0 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities soared 196.19% in 2022, then declined 9.41% in 2025.
  • Over 5 years, Total Non-Current Liabilities stood at $10.2 million in 2022, then soared by 55.71% to $15.8 million in 2023, then dropped by 6.0% to $14.9 million in 2024, then gained by 21.42% to $18.0 million in 2025, then jumped by 60.55% to $29.0 million in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $29.0 million, $18.0 million, and $18.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 5.92 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 7.74 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 40.00 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 1.53 Bn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.88 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 9.32 Bn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 4.20 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 1.17 Bn
10 Alpha Tau Medical 1.32 Bn 1.32 Bn - 80.56 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 80.56 Mn
Mar 31, 2026 28.97 Mn
Dec 31, 2025 18.05 Mn
Sep 30, 2025 17.97 Mn
Jun 30, 2025 16.18 Mn
Mar 31, 2025 14.84 Mn
Dec 31, 2024 14.86 Mn
Sep 30, 2024 14.98 Mn
Jun 30, 2024 15.58 Mn
Mar 31, 2024 16.38 Mn
Dec 31, 2023 15.81 Mn
Sep 30, 2023 10.65 Mn
Jun 30, 2023 13.23 Mn
Mar 31, 2023 11.55 Mn
Dec 31, 2022 10.15 Mn
Mar 31, 2022 8.14 Mn
Dec 31, 2021 4.41 Mn
Mar 31, 2021 -8.46 Mn
Dec 31, 2020 2.09 Mn